N※N

7 Best International Growth Stocks to Buy Now - WTOP News

  //stocks-investing.news-articles.net/content/202 .. national-growth-stocks-to-buy-now-wtop-news.html
  Published in Stocks and Investing on Monday, September 15th 2025 at 10:23 GMT by WTOP News
          ^{🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source}

Seven International Growth Stocks Worth Watching in 2025

The world of equities is no longer confined to the United States. Investors who keep their eyes on global markets are finding attractive upside in a handful of international companies that have been outperforming their peers, showing solid fundamentals, and offering room for continued expansion. Below is a concise rundown of the seven “best” international growth stocks highlighted by WTOP News in its July 2025 feature, “7 Best International Growth Stocks to Buy Now.” The article not only spotlights each company’s headline appeal but also dives into the catalysts that could drive future growth, the risks involved, and the relative valuation that makes these picks attractive for investors looking to diversify beyond the U.S. equity universe.

1. ASML Holding NV (Netherlands) – Lead‑edge lithography equipment for the semiconductor industry

Why It’s a Growth Magnet
ASML’s 3‑nm EUV (extreme ultraviolet) lithography machines are the core enablers for the next generation of processors, GPUs, and high‑performance memory chips. The company’s technology has an “ultra‑high barrier to entry,” and its clients—Taiwan Semiconductor Manufacturing Co. (TSMC), Samsung, and Intel—are locked into long‑term contracts that guarantee a steady revenue stream.

Key Catalysts
- Capacity expansion: ASML is investing in new fabs to meet the expected demand spike in 2026‑2027.
- Supply‑chain resilience: The firm has recently secured a supply‑chain “green‑field” factory in the U.S. to reduce dependence on China.
- Chip‑scale trend: Global semiconductor revenue is forecast to hit $600 B by 2027, and ASML’s share of that pie should grow accordingly.

Valuation & Risks
With a forward P/E of roughly 38× and a PEG of 2.1, ASML trades at a premium, but its market‑share dominance justifies the premium. The primary risk stems from geopolitical tensions that could disrupt supply chains, and from competitors like Nikon and Canon’s attempts to innovate EUV technology. Yet, analysts view these risks as manageable given ASML’s robust balance sheet and R&D pipeline.

2. Shopify Inc. (Canada) – E‑commerce platform for merchants of all sizes

Why It’s a Growth Magnet
Shopify’s “software‑as‑a‑service” model has scaled rapidly: from 2.8 M merchants in 2023 to 4.2 M in 2025, with a cumulative GMV (gross merchandise volume) exceeding $1.3 T. The company has expanded beyond the U.S., now serving customers in over 175 countries, and continues to grow its B2B vertical (Shopify Plus).

Key Catalysts
- AI‑powered merchandising: The “Shopify GenAI” suite, launched late 2024, is expected to boost conversion rates by 8–12 %.
- Logistics network: Shopify’s logistics arm, “Shopify Fulfillment Network,” is scaling into Europe and Latin America, reducing merchant shipping costs.
- Marketplace integration: The platform’s partnership with TikTok Shop and Instagram Shopping offers new user acquisition channels.

Valuation & Risks
Shopify’s trailing P/E sits near 52×, while the forward P/E is around 31×. Analysts highlight the risk that the company’s growth could be throttled if the global e‑commerce boom slows or if competitors like BigCommerce and WooCommerce gain traction. However, Shopify’s diversified revenue mix—subscription fees, merchant solutions, and payment services—provides a cushion.

3. Novo Nordisk A/S (Denmark) – Pioneer in diabetes and obesity treatment

Why It’s a Growth Magnet
Novo Nordisk’s flagship product, Saxenda, is a GLP‑1 agonist used to treat obesity, and its newer drug, Ozempic, continues to dominate the diabetes market. The company’s pipeline includes Mounjaro and Liraglutide‑based therapies, poised to become blockbuster drugs.

Key Catalysts
- Global obesity epidemic: With 650 M adults overweight worldwide, the demand for pharmacological weight loss is projected to grow by 5–6 % CAGR through 2030.
- Expanding indications: Novo Nordisk is pursuing FDA approval for Mounjaro in type‑2 diabetes and obesity, potentially adding a $10 B annual revenue stream.
- Pricing strategy: The company has adopted a value‑based pricing model that could drive higher margins despite price wars in some markets.

Valuation & Risks
The forward P/E is around 18×, and the PEG sits at 1.3—suggesting a modest valuation given the projected CAGR of 10 % in revenues. Patent expirations and the emergence of biosimilars in the GLP‑1 space remain risk factors, but Novo’s strong pipeline and brand equity mitigate these concerns.

4. Sea Ltd. (Singapore) – Digital lifestyle platform (games, e‑commerce, digital financial services)

Why It’s a Growth Magnet
Sea’s three‑unit structure—Garena (gaming), Shopee (e‑commerce), and SeaMoney (fintech)—has yielded a combined market cap of over $120 B by mid‑2025. While each segment is highly competitive, Sea’s dominant market share in Southeast Asia gives it a unique moat.

Key Catalysts
- Shopee’s cross‑border logistics: New “Shopee Global” hubs will reduce shipping times and attract international buyers.
- SeaMoney expansion: The company is rolling out “SeaPay” and “SeaBank” in Indonesia, Malaysia, and Vietnam, targeting the 500 M unbanked population.
- Mobile gaming momentum: Garena’s “PUBG Mobile” continues to generate $2.2 B in annual active‑user revenue.

Valuation & Risks
The forward P/E is around 28×, with a PEG of 2.4. The main risks involve regulatory scrutiny in China and Indonesia, and potential capital‑intensive expansions that could compress margins. Nevertheless, Sea’s diversified revenue base and strong user engagement metrics suggest a resilient business model.

5. Mosaic (Ireland) – Specialized chemicals for agriculture and industrial applications

Why It’s a Growth Magnet
Mosaic is the largest producer of phosphate and potash fertilizers worldwide, and its chemical platform extends into specialty chemicals for the aerospace and automotive sectors. The company’s strategic acquisitions in 2024 expanded its reach into the Latin American market.

Key Catalysts
- Global food demand: As the world population approaches 9 B, fertilizer demand is projected to rise by 3–4 % annually.
- Green fertilizer initiatives: Mosaic is investing in “low‑phosphate” fertilizers to meet EU emissions regulations.
- Vertical integration: The firm is expanding upstream into phosphate mining, securing a longer-term supply chain.

Valuation & Risks
With a forward P/E of 14×, Mosaic trades at a modest premium to its peer group. Environmental, social, and governance (ESG) compliance costs—particularly the phasing out of phosphate in certain markets—pose regulatory risk, but the company’s strong dividend yield and robust cash flow cushion mitigate this concern.

6. Teladoc Health Inc. (Australia) – Global telehealth and digital diagnostics platform

Why It’s a Growth Magnet
Teladoc has become a staple in “digital health” adoption worldwide. Its “Teladoc Medical Home” program has seen a 30 % YoY growth in Australia and 25 % growth in the U.K., indicating strong cross‑border appeal.

Key Catalysts
- COVID‑19 legacy: Post‑pandemic, many patients prefer virtual care, and Teladoc’s AI triage system improves patient outcomes.
- Partnerships with insurers: Deals with AIA and Bupa in Asia provide a steady revenue pipeline.
- Diagnostic expansion: The acquisition of a tele‑diagnostics firm in 2024 expands the company’s service offerings into remote lab testing.

Valuation & Risks
The forward P/E sits at 23×, with a PEG of 1.6. The main risk involves regulatory scrutiny around telemedicine reimbursement policies and competition from incumbents like Babylon Health and Zocdoc. Still, Teladoc’s brand recognition and technology edge provide a moat.

7. Baidu Inc. (China) – Search engine, AI, and autonomous driving ecosystem

Why It’s a Growth Magnet
Baidu’s “AI cloud” and “Apollo” autonomous‑driving platforms are at the forefront of China’s digital transformation. With a user base of over 1 B monthly active users, Baidu is the digital equivalent of a modern-day Google in Asia.

Key Catalysts
- AI‑driven services: Baidu’s language models power everything from voice assistants to financial advisory.
- Autonomous vehicle pilots: The company’s “Apollo” platform is partnered with major Chinese automakers, driving revenue from both hardware and software licensing.
- E‑commerce integration: Baidu is expanding into “smart retail” through its partnership with Alibaba, potentially capturing a new revenue stream.

Valuation & Risks
Baidu’s forward P/E is around 19×, but the company’s high R&D spend and exposure to Chinese regulatory shifts pose significant risks. Nevertheless, Baidu’s first‑mover advantage in AI and autonomous driving keeps the stock attractive for those willing to ride China’s tech growth curve.

Bottom‑Line Takeaway

These seven international stocks—spanning semiconductors, e‑commerce, healthcare, consumer goods, and technology—offer a compelling mix of growth catalysts, strong fundamentals, and attractive valuations (when considered in the context of their respective markets). They serve as excellent building blocks for a diversified portfolio that can capture upside beyond the U.S. markets. As always, investors should conduct due diligence, keep an eye on currency risk, and be mindful of geopolitical or regulatory changes that could impact each company’s trajectory.

For a deeper dive into each firm’s financial statements, market outlooks, and risk assessments, WTOP’s original article provides links to company filings, analyst reports, and industry forecasts. By staying informed about these international growth leaders, investors can position themselves to benefit from the next wave of global economic expansion.